Comparison of Hyalomatrix & Integra Wound Matrix on Burn Wounds

Clinical Trial Summary

The purpose of this randomized, comparative study is to determine whether Hyalomatrix is as effective as IntegraTM Meshed Bilayer Wound Matrix when used in subjects who receive concurrent treatments with both products on their first and/or second degree burns located on both hands.

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02735408` - Kinesiotape Tensiomyography in Low Back Region	Phase 1
Completed	`NCT02945098` - Kinesio Taping in Muscle Damage Response Induced by Eccentric Exercise	N/A
Completed	`NCT03216629` - Sorry Not Sorry: Apologizing and Its Effect on Discomfort During Dressing Removal	N/A
Withdrawn	`NCT02353507` - Comparison of Chitosan and Carboxymethylcellulose Silver Dressings on Burn Wounds in Pediatric and Adult Subjects	Phase 4

See also

Status

Clinical Trial

Phase

Recruiting

NCT02735408 - Kinesiotape Tensiomyography in Low Back Region

Phase 1

Completed

NCT02945098 - Kinesio Taping in Muscle Damage Response Induced by Eccentric Exercise

N/A

Completed

NCT03216629 - Sorry Not Sorry: Apologizing and Its Effect on Discomfort During Dressing Removal

N/A

Withdrawn

NCT02353507 - Comparison of Chitosan and Carboxymethylcellulose Silver Dressings on Burn Wounds in Pediatric and Adult Subjects

Phase 4

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT02363543
Study type	Interventional
Source	Medline Industries
Contact
Status	Withdrawn
Phase	Phase 4
Start date	February 2016
Completion date	July 2016

Comparison of Hyalomatrix and Integra Wound Matrix on Burn Wounds — Hyalomatrix

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms